ORGO insider transaction filings
Organogenesis Holdings Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-04-24. Screen ORGO transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-24 | 4 | Grow Brian — Chief Commercial Officer | Option exercise (M): 958 @ $1.24 · Option exercise (M): 958 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Driscoll Michael Joseph — Director | Purchase (P): 10,000 @ $2.67 | EDGAR |
| 2026-03-11 | 4 | Leibowitz Arthur S — Director | Purchase (P): 5,000 @ $2.68 | EDGAR |
| 2026-03-03 | 4 | Cavorsi Robert — Vice President, Strategy | Tax withholding (F): 700 @ $3.21 | EDGAR |
| 2026-03-03 | 4/A | Montecalvo Antonio S. — Vice President, Health Policy | Grant/award (A): 11,330 @ $0 · Tax withholding (F): 3,778 @ $3.84 | EDGAR |
| 2026-03-03 | 4/A | Gillheeney Gary S. — President and CEO, Director | Grant/award (A): 188,856 @ $0 · Tax withholding (F): 91,311 @ $3.84 | EDGAR |
| 2026-03-03 | 4/A | Grow Brian — Chief Commercial Officer | Grant/award (A): 48,818 @ $0 · Tax withholding (F): 11,887 @ $3.84 | EDGAR |
| 2026-03-03 | 4/A | Bilbo Patrick — Chief Operating Officer | Grant/award (A): 49,102 @ $0 · Tax withholding (F): 16,375 @ $3.84 | EDGAR |
| 2026-03-03 | 4/A | Francisco David — Chief Financial Officer | Grant/award (A): 44,040 @ $0 · Tax withholding (F): 14,687 @ $3.84 | EDGAR |
| 2026-03-03 | 4/A | Cavorsi Robert — Vice President, Strategy | Grant/award (A): 16,454 @ $0 · Tax withholding (F): 5,487 @ $3.84 | EDGAR |
| 2026-03-03 | 4/A | Freedman Lori — Chief Admin. and Legal Officer | Grant/award (A): 43,212 @ $0 · Tax withholding (F): 14,411 @ $3.84 | EDGAR |
| 2026-02-20 | 4 | Cavorsi Robert — Vice President, Strategy | Grant/award (A): 93,750 @ $0 · Grant/award (A): 16,290 @ $0 · Tax withholding (F): 5,432 @ $3.84 · Grant/award (A): 53,452 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Francisco David — Chief Financial Officer | Grant/award (A): 195,312 @ $0 · Grant/award (A): 43,602 @ $0 · Tax withholding (F): 14,541 @ $3.84 · Grant/award (A): 111,358 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Grow Brian — Chief Commercial Officer | Grant/award (A): 234,375 @ $0 · Grant/award (A): 48,330 @ $0 · Tax withholding (F): 11,768 @ $3.84 · Grant/award (A): 133,630 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Bilbo Patrick — Chief Operating Officer | Grant/award (A): 210,937 @ $0 · Grant/award (A): 48,612 @ $0 · Tax withholding (F): 16,212 @ $3.84 · Grant/award (A): 120,267 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Gillheeney Gary S. — President and CEO, Director | Grant/award (A): 890,625 @ $0 · Grant/award (A): 186,968 @ $0 · Tax withholding (F): 90,398 @ $3.84 · Grant/award (A): 507,795 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Driscoll Michael Joseph — Director | Grant/award (A): 48,828 @ $0 | EDGAR |
| 2026-02-20 | 4 | Montecalvo Antonio S. — Vice President, Health Policy | Grant/award (A): 40,625 @ $0 · Grant/award (A): 11,218 @ $0 · Tax withholding (F): 3,741 @ $3.84 · Grant/award (A): 23,162 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Quintero Gilberto — Director | Grant/award (A): 48,828 @ $0 | EDGAR |
| 2026-02-20 | 4 | Duraibabu Prathyusha — Director | Grant/award (A): 48,828 @ $0 | EDGAR |
| 2026-02-20 | 4 | Lustig Garrett — Director | Grant/award (A): 48,828 @ $0 | EDGAR |
| 2026-02-20 | 4 | Korfin Michele Ilene — Director | Grant/award (A): 48,828 @ $0 | EDGAR |
| 2026-02-20 | 4 | Giacomin Jon L — Director | Grant/award (A): 48,828 @ $0 | EDGAR |
| 2026-02-20 | 4 | Leibowitz Arthur S — Director | Grant/award (A): 48,828 @ $0 | EDGAR |
| 2026-02-20 | 4 | Freedman Lori — Chief Admin. and Legal Officer | Grant/award (A): 203,125 @ $0 · Grant/award (A): 42,780 @ $0 · Tax withholding (F): 14,267 @ $3.84 · Grant/award (A): 115,812 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Francisco David — Chief Financial Officer | Tax withholding (F): 3,898 @ $3.73 · Tax withholding (F): 21,412 @ $3.73 · Tax withholding (F): 13,369 @ $3.73 · Tax withholding (F): 13,769 @ $3.73 | EDGAR |
| 2026-02-18 | 4 | Bilbo Patrick — Chief Operating Officer | Tax withholding (F): 5,114 @ $3.73 · Tax withholding (F): 28,331 @ $3.73 · Tax withholding (F): 15,617 @ $3.73 · Tax withholding (F): 15,352 @ $3.73 | EDGAR |
| 2026-02-18 | 4 | Cavorsi Robert — Vice President, Strategy | Tax withholding (F): 6,667 @ $3.73 · Tax withholding (F): 5,549 @ $3.73 · Tax withholding (F): 5,442 @ $3.73 | EDGAR |
| 2026-02-18 | 4 | Gillheeney Gary S. — President and CEO, Director | Tax withholding (F): 24,340 @ $3.73 · Tax withholding (F): 78,646 @ $3.73 · Tax withholding (F): 82,815 @ $3.73 · Tax withholding (F): 85,605 @ $3.73 | EDGAR |
| 2026-02-18 | 4 | Grow Brian — Chief Commercial Officer | Tax withholding (F): 3,346 @ $3.73 · Tax withholding (F): 18,910 @ $3.73 · Tax withholding (F): 10,559 @ $3.73 · Tax withholding (F): 11,144 @ $3.73 | EDGAR |
| 2026-02-18 | 4 | Montecalvo Antonio S. — Vice President, Health Policy | Tax withholding (F): 1,389 @ $3.73 · Tax withholding (F): 9,607 @ $3.73 · Tax withholding (F): 4,100 @ $3.73 · Tax withholding (F): 3,523 @ $3.73 | EDGAR |
| 2026-02-18 | 4 | Freedman Lori — Chief Admin. and Legal Officer | Tax withholding (F): 4,043 @ $3.73 · Tax withholding (F): 24,428 @ $3.73 · Tax withholding (F): 12,761 @ $3.73 · Tax withholding (F): 13,510 @ $3.73 | EDGAR |
| 2025-12-18 | 4 | NUSSDORF GLENN H — Director | Sale (S): 200,000 @ $5.14 | EDGAR |
| 2025-11-26 | 4 | NUSSDORF GLENN H — Director, 10% owner | Sale (S): 100,000 @ $5.34 · Sale (S): 12,043 @ $5.30 · Sale (S): 187,957 @ $5.29 | EDGAR |
| 2025-11-03 | 4 | NUSSDORF GLENN H — Director, 10% owner | Purchase (P): 251,001 @ $3.09 · Purchase (P): 107,494 @ $2.99 · Sale (S): 4,156 @ $3.50 · Sale (S): 18,620 @ $3.56 | EDGAR |
| 2025-08-13 | 4 | Grow Brian — Chief Commercial Officer | Option exercise (M): 4,060 @ $2.47 · Tax withholding (F): 2,173 @ $4.62 · Option exercise (M): 4,060 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | Cavorsi Robert — Vice President, Strategy | Tax withholding (F): 360 @ $4.46 | EDGAR |
| 2025-06-06 | 4 | Freedman Lori — Chief Admin. and Legal Officer | Purchase (P): 100,863 @ $2.82 · Purchase (P): 142,379 @ $2.91 · Purchase (P): 9,022 @ $2.99 | EDGAR |
| 2025-03-12 | 4 | Cavorsi Robert — Vice President, Strategy | Tax withholding (F): 210 @ $5.16 · Tax withholding (F): 61 @ $5.16 | EDGAR |
| 2025-03-06 | 4 | Driscoll Michael Joseph — Director | Sale (S): 25,000 @ $5.10 | EDGAR |
| 2025-03-04 | 4 | Cavorsi Robert — Vice President, Strategy | Tax withholding (F): 667 @ $6.21 | EDGAR |
| 2025-02-21 | 4 | Cavorsi Robert — Vice President, Strategy | Grant/award (A): 61,705 @ $0 · Grant/award (A): 63,830 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Bilbo Patrick — Chief Operating Officer | Grant/award (A): 184,136 @ $0 · Grant/award (A): 190,475 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Montecalvo Antonio S. — Vice President, Health Policy | Grant/award (A): 42,493 @ $0 · Grant/award (A): 43,956 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Grow Brian — Chief Commercial Officer | Grant/award (A): 183,067 @ $0 · Grant/award (A): 189,369 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Francisco David — Chief Financial Officer | Grant/award (A): 165,156 @ $0 · Grant/award (A): 170,841 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Quintero Gilberto — Director | Grant/award (A): 49,575 @ $0 | EDGAR |
| 2025-02-21 | 4 | Lustig Garrett — Director | Grant/award (A): 49,575 @ $0 | EDGAR |
| 2025-02-21 | 4 | Korfin Michele Ilene — Director | Grant/award (A): 49,575 @ $0 | EDGAR |
| 2025-02-21 | 4 | Gillheeney Gary S. — President and CEO, Director | Grant/award (A): 708,215 @ $0 · Grant/award (A): 732,596 (derivative) @ $0 | EDGAR |
Recent 8-K events — Organogenesis Holdings Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-12-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-25 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ORGO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →